Market News

Stay updated with the latest market trends, earnings, and economic indicators.

Showing news for:SPARCHealthcare
Clear all filters
Trade Spotlight: How should you trade Torrent Power, Bajaj Auto, Hindustan Aeronautics, Sun Pharma, PFC, Aditya Birla Capital, and others on June 23?
positive
Moneycontrol NaNd ago

Trade Spotlight: How should you trade Torrent Power, Bajaj Auto, Hindustan Aeronautics, Sun Pharma, PFC, Aditya Birla Capital, and others on June 23?

The market trend remains healthy, but a sustained close above long-term moving averages is needed for further sharp upside. Below are some short-term trading ideas to consider.

ABCAPITALABFRLABGSECABLBLABRELABSL10BANKABSLAMCABSLBANETFABSLLIQUIDABSLNN50ETABSLPSEAKCAPITBAJAJ-AUTOBIRLACORPNBIRLAMONEYBSLGOLDETFBSLNIFTYBSLSENETFGCPCAPGSEC10ABSLGVPILHALHEALTHYLTGILTBEESMOCAPITALMOMENTUMNIFTYQLITYPFCSILVERSPARCTECHTORNTPOWERAutomobile and Auto ComponentsCapital Goods
Buy Ajanta Pharma; target of Rs 3400: Prabhudas Lilladher
positive
Moneycontrol NaNd ago

Buy Ajanta Pharma; target of Rs 3400: Prabhudas Lilladher

Prabhudas Lilladher is bullish on Ajanta Pharma has recommended buy rating on the stock with a target price of Rs 3400 in its research report dated May 06, 2026.

AJANTPHARMSPARCHealthcare
Buy Ajanta Pharma; target of Rs 3400: Motilal Oswal
positive
Moneycontrol NaNd ago

Buy Ajanta Pharma; target of Rs 3400: Motilal Oswal

Motilal Oswal is bullish on Ajanta Pharma has recommended buy rating on the stock with a target price of Rs 3400 in its research report dated May 05, 2026.

AJANTPHARMMOALPHA50MOBANK10MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUESPARCFinancial ServicesHealthcare
Hold Torrent Pharma: target of Rs 4150: ICICI Securities
neutral
Moneycontrol NaNd ago

Hold Torrent Pharma: target of Rs 4150: ICICI Securities

ICICI Securities recommended hold rating on Torrent Pharma with a target price of Rs 4150 in its research report dated February 16, 2026.

SPARCHealthcare
Nifty Pharma jumps nearly 2%; Dr Reddy's, Sun Pharma and Cipla lead gains, dominate Nifty gainers list
positive
Moneycontrol NaNd ago

Nifty Pharma jumps nearly 2%; Dr Reddy's, Sun Pharma and Cipla lead gains, dominate Nifty gainers list

Pharma stocks led the gains on benchmark Nifty 50 and the BSE Midcap index on Tuesday. Dr Reddy's, Sun Pharma and Cipla were the top 3 Nifty gainers, amid news reports that the US FDA has asked Indian firms to help address a shortage of ifosfamide injection.

ABSL10BANKABSLBANETFABSLNN50ETABSLPSEBANK10ADDBANKIETFBSEBSLNIFTYBSLSENETFGCIPLAGILT10BETAGILT5BETAGILT5YBEESGROWWMC150GSEC10IETFGSEC5IETFHDFCMID150HEALTHYLICNMID100MID150MID150BEESMID150CASEMIDCAPMIDCAPADDMIDCAPBETAMIDCAPETFMIDCAPIETFMIDQ50ADDMIDSELIETFMOBANK10MOMENTUMNIFTYQLITYPHARMABEESPVTBANIETFSBINMID150SDL26BEESSPARCTECHTOP10ADDTOP15IETFTOP20Financial ServicesHealthcare
Sun Pharma Q4 Results: Net profit jumps 26% to Rs 2,714 crore; board proposes Rs 5 final dividend
positive
Moneycontrol NaNd ago

Sun Pharma Q4 Results: Net profit jumps 26% to Rs 2,714 crore; board proposes Rs 5 final dividend

Sun Pharma Q4 FY26 Results: India formulations business remained its largest market, with sales rising 14.8 percent year-on-year to Rs 4,835.9 crore in the quarter. The India business contributed 33.2 percent of consolidated sales.

DIVIDENDGSEC10ABSLSPARCFinancial ServicesHealthcare
Stocks to Watch Today: HDB Financial, Tejas Networks, Aurobindo Pharma, GHV Infra, John Cockerill, Brigade, Container Corporation, UFO Moviez in focus on 16 April
positive
Moneycontrol NaNd ago

Stocks to Watch Today: HDB Financial, Tejas Networks, Aurobindo Pharma, GHV Infra, John Cockerill, Brigade, Container Corporation, UFO Moviez in focus on 16 April

Stocks to Watch, 16 Apr: Stocks like ICICI Lombard General Insurance Company, HDB Financial Services, GTPL Hathway, Tejas Networks, GMR Airports, Aurobindo Pharma, GHV Infra Projects, John Cockerill India, Brigade Enterprises, Rubicon Research, Suraj Estate Developers, and UFO Moviez India will be in focus on April 16.

AUROPHARMABRIGADECONCORFOCUSGICREGMRAIRPORTGODIGITGTPLHATHWAYHDBFSICICIGIICICIPRULIINFRAJMFINANCILRPPINFRARUBICONSPARCSURAJESTSURAJLTDTEJASNETUFOCapital GoodsConstruction
Trade Spotlight: How should you trade SPARC, Gland Pharma, Techno Electric, GE Power India, Supriya Lifescience, and others on May 25?
positive
Moneycontrol NaNd ago

Trade Spotlight: How should you trade SPARC, Gland Pharma, Techno Electric, GE Power India, Supriya Lifescience, and others on May 25?

A strong move beyond last week's high is required for further market upside; otherwise, range-bound trading may continue. Below are some short-term trading ideas to consider.

GLANDGVPILHPLSPARCSUPRIYATECHNOECapital GoodsConstruction
Sun Pharma Q4: Execution risk caps upside
positive
Moneycontrol NaNd ago

Sun Pharma Q4: Execution risk caps upside

Strong speciality pipeline supports growth, but Organon integration and rich valuation limit upside visibility

BSLGOLDETFSPARCSPECIALITYConsumer ServicesHealthcare
Hold Natco Pharma: target of Rs 1000: ICICI Securities
positive
Moneycontrol NaNd ago

Hold Natco Pharma: target of Rs 1000: ICICI Securities

ICICI Securities recommended hold rating on Natco Pharma with a target price of Rs 1000 in its research report dated May 31, 2026.

NATCOPHARMSPARCHealthcare
Reduce Sudeep Pharma; target of Rs 627: Prabhudas Lilladher
positive
Moneycontrol NaNd ago

Reduce Sudeep Pharma; target of Rs 627: Prabhudas Lilladher

Prabhudas Lilladher recommended reduce rating on Sudeep Pharma with a target price of Rs 627 in its research report dated May 22, 2026.

SPARCSUDEEPPHRMHealthcare
Hold Aurobindo Pharma; target of Rs 1400: Prabhudas Lilladher
positive
Moneycontrol NaNd ago

Hold Aurobindo Pharma; target of Rs 1400: Prabhudas Lilladher

Prabhudas Lilladher recommended hold rating on Aurobindo Pharma with a target price of Rs 1400 in its research report dated May 25, 2026.

AUROPHARMASPARCHealthcare